Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (48)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Nwosu, V.
Right arrow Articles by Sheridan, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nwosu, V.
Right arrow Articles by Sheridan, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2001, Vol. 10, No. 20 2313-2318
© 2001 Oxford University Press

Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease

Veronica Nwosu, John Carpten1,+, Jeffrey M. Trent1 and Richard Sheridan2

Department of Biology, North Carolina Central University, Durham, NC 27707, USA, 1National Human Genome Research Institute, NIH, Bethesda, MD 20892, USA and 2DNA Sciences Laboratories, 3500 Paramount Parkway, Morrisville, NC 27560, USA

Prostate cancer is a complex, multifactorial disease with genetic and environmental factors involved in its etiology. The search for genetic determinants involved in the disease has proven to be challenging, in part because such complex diseases are often not amenable to characterization by linkage analysis and positional cloning as is the case for diseases with simple Mendelian genetic inheritance. Prostate cancer susceptibility loci that have been reported so far include HPC1 (1q24–q25), PCAP (1q42–q43), HPCX (Xq27–q28), CAPB (1p36), HPC20 (20q13), HPC2/ELAC2 (17p11) and 16q23. Prostate cancer aggressiveness loci have also been reported (5q31–q33, 7q32 and 19q12). Further complicating the process is the existence of polymorphisms in several genes associated with prostate cancer including, AR, PSA, SRD5A2, VDR and CYP isoforms. These polymorphisms, however, are not thought to be highly penetrant alleles in families at high risk for prostate cancer. It is clear that prostate cancer etiology involves several genetic loci with no major gene accounting for a large proportion of susceptibility to the disease.

+ To whom correspondence should be addressed. Tel: +1 301 435 5626; Fax: +1 301 435 5465; Email: jdc@nhgri.nih.gov


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
X. Wang, F. Wang, K. Taniguchi, R. S. Seelan, L. Wang, K. E. Zarfas, S. K. McDonnell, C. Qian, K. Pan, Y. Lu, et al.
Truncating Variants in p53AIP1 Disrupting DNA Damage-Induced Apoptosis Are Associated with Prostate Cancer Risk
Cancer Res., November 1, 2006; 66(21): 10302 - 10307.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Li and B. C. Tai
RNASEL Gene Polymorphisms and the Risk of Prostate Cancer: a Meta-analysis.
Clin. Cancer Res., October 1, 2006; 12(19): 5713 - 5719.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. Simard, M.-L. Ricketts, S. Gingras, P. Soucy, F. A. Feltus, and M. H. Melner
Molecular Biology of the 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase Gene Family
Endocr. Rev., June 1, 2005; 26(4): 525 - 582.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. P. Larson, Y. Ding, L. S-C. Cheng, C. Lundberg, V. Gagalang, G. Rivas, L. Geller, J. Weitzel, D. MacDonald, J. Archambeau, et al.
Genetic Linkage of Prostate Cancer Risk to the Chromosome 3 Region Bearing FHIT
Cancer Res., February 1, 2005; 65(3): 805 - 814.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
C. A. Heinlein and C. Chang
Androgen Receptor in Prostate Cancer
Endocr. Rev., April 1, 2004; 25(2): 276 - 308.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
B. A. Rybicki, D. V. Conti, A. Moreira, M. Cicek, G. Casey, and J. S. Witte
DNA Repair Gene XRCC1 and XPD Polymorphisms and Risk of Prostate Cancer
Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 23 - 29.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
H. W. Mohrenweiser
Genetic Variation and Exposure Related Risk Estimation: Will Toxicology Enter a New Era? DNA Repair and Cancer as a Paradigm
Toxicol Pathol, January 1, 2004; 32(1_suppl): 136 - 145.
[Abstract] [PDF]

Home page
 Clin. Cancer Res.Home page
E. H. Seppala, T. Ikonen, V. Autio, A. Rokman, N. Mononen, M. P. Matikainen, T. L. J. Tammela, and J. Schleutker
Germ-Line Alterations in MSR1 Gene and Prostate Cancer Risk
Clin. Cancer Res., November 1, 2003; 9(14): 5252 - 5256.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. J. Plummer, D. V. Conti, P. L. Paris, A. P. Curran, G. Casey, and J. S. Witte
CYP3A4 and CYP3A5 Genotypes, Haplotypes, and Risk of Prostate Cancer
Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 928 - 932.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
W.A. Schulz, M. Burchardt, and M.V. Cronauer
Molecular biology of prostate cancer
Mol. Hum. Reprod., August 1, 2003; 9(8): 437 - 448.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. Marchesani, A. Hakkarainen, T.-P. Tuomainen, J. Kaikkonen, E. Pukkala, P. Uimari, E. Seppala, M. Matikainen, O.-P. Kallioniemi, J. Schleutker, et al.
New Paraoxonase 1 Polymorphism I102V and the Risk of Prostate Cancer in Finnish Men
J Natl Cancer Inst, June 4, 2003; 95(11): 812 - 818.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. Walker-Daniels, A. R. Hess, M. J.C. Hendrix, and M. S. Kinch
Differential Regulation of EphA2 in Normal and Malignant Cells
Am. J. Pathol., April 1, 2003; 162(4): 1037 - 1042.
[Full Text] [PDF]

Home page
 CarcinogenesisHome page
Z. Liao, T. W.-M. Boileau, J. W. Erdman Jr, and S. K. Clinton
Interrelationships among angiogenesis, proliferation, and apoptosis in the tumor microenvironment during N-methyl-N-nitrosourea androgen-induced prostate carcinogenesis in rats
Carcinogenesis, October 1, 2002; 23(10): 1701 - 1712.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Simard, M. Dumont, P. Soucy, and F. Labrie
Perspective: Prostate Cancer Susceptibility Genes
Endocrinology, June 1, 2002; 143(6): 2029 - 2040.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.